Skip to Main content Skip to Navigation
Journal articles

Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Andrei Tchirkov 1, 2, * Jean-Louis Couderc 3 Bernard Périssel 2 Carole Goumy 2 Aline Regnier 4 Nancy Uhrhammer 1 Pierre Verrelle 1 M. Berger 5
* Corresponding author
1 Centre Jean Perrin
2 Service de Cytogénétique Médicale
3 Interactions génétiques et cellulaires au cours de la différenciation
4 Service de Médecine Interne
5 Service d'Hématologie
Résumé : N.A
Complete list of metadatas
https://www.hal.inserm.fr/inserm-00077396
Contributor : Jean-Louis Couderc <>
Submitted on : Tuesday, March 6, 2007 - 2:57:43 PM
Last modification on : Friday, November 8, 2019 - 10:55:08 AM
Document(s) archivé(s) le : Monday, April 5, 2010 - 9:52:32 PM

Files

Vignette du document
BCR-ABL.pdf

Identifiers

Collections

FNCLCC | CJP | PRES_CLERMONT | ACL-SVSAE

Citation

Andrei Tchirkov, Jean-Louis Couderc, Bernard Périssel, Carole Goumy, Aline Regnier, et al.. Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.. Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2006, 20 (1), pp.167-8. ⟨10.1038/sj.leu.2404012⟩. ⟨inserm-00077396⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

456

Files downloads

649

Contact

Informations

CCSD